Elsevier

Clinical Oncology

Volume 34, Issue 7, July 2022, Pages e320-e321
Clinical Oncology

Letter
The Real Value of Stereotactic Ablative Radiotherapy (SABR) in Oligometastases: A Journey Into the Literature Evidence

https://doi.org/10.1016/j.clon.2022.04.003Get rights and content

Section snippets

Funding

Not available.

Conflict of interest

The authors declare no conflict of interest.

References (14)

There are more references available in the full text version of this article.

Cited by (0)

View full text